T. Doležal
发表
L. Vlček,
B. Janský,
Jan Kocum,
2020
.
M. Procházková,
T. Doležal,
M. Kršiak,
2009,
Physiological research.
T. Doležal,
2006
.
T. Doležal,
H. Doležalová,
M. Herold,
2022,
Vnitrni lekarstvi.
T. Doležal,
Š. Veselá,
T. Mlcoch,
2018,
Value in Health.
T. Doležal,
H. Doležalová,
Z. Adamová,
2020
.
A. Poprach,
B. Melichar,
T. Buchler,
2020,
Cancers.
K. Pavelka,
D. Suchý,
T. Doležal,
2017,
Expert review of pharmacoeconomics & outcomes research.
J. Klimeš,
T. Doležal,
M. Vocelka,
2013
.
M. Kratochvíl,
M. Svetlak,
A. Pokorná,
2022,
Critical Care.
D. Dvořáková,
J. Vorlíc̆ek,
M. Doubek,
2006,
Bone Marrow Transplantation.
J. Klimeš,
M. Macek,
M. Turnovec,
2015,
The European Journal of Health Economics.
P. Arenberger,
T. Doležal,
P. Cetkovska,
2017,
International journal of dermatology.
J. Klimeš,
T. Doležal,
M. Vocelka,
2012
.
T. Doležal,
Jan Tužil,
K. Chadimová,
2022,
Expert review of pharmacoeconomics & outcomes research.
M. Tichý,
T. Doležal,
P. Cetkovska,
2022,
Dermatologic therapy.
M. Arenbergerova,
P. Arenberger,
T. Doležal,
2021,
Dermatology and Therapy.
M. Dufek,
T. Doležal,
H. Doležalová,
2022,
Pharmaceuticals.
T. Doležal,
K. Nemecek,
M. Kršiak,
2002,
European Journal of Clinical Pharmacology.
M. Trněný,
M. Lánská,
T. Doležal,
2016,
Neoplasma.
T. Doležal,
M. Kvapil,
A. Petříková,
2010
.
T. Doležal,
Barbora Decker,
T. Mlčoch,
2021,
Applied Health Economics and Health Policy.
M. Arenbergerova,
P. Arenberger,
T. Doležal,
2022,
Central European journal of public health.
T. Doležal,
D. Szmurło,
K. Kruntorádová,
2014,
Expert review of pharmacoeconomics & outcomes research.
K. Pavelka,
D. Suchý,
T. Doležal,
2018,
The Patient - Patient-Centered Outcomes Research.
T. Doležal,
J. Prausová,
V. Vondráček,
2021,
International journal of radiation oncology, biology, physics.
P. Kneppo,
V. Rogalewicz,
G. Donin,
2018,
IFMBE Proceedings.
T. Doležal,
M. Kršiak,
2002,
Physiological research.
T. Doležal,
M. Kršiak,
2002,
Naunyn-Schmiedeberg's Archives of Pharmacology.
B. Winblad,
M. Fioravanti,
I. Milanov,
2008,
Clinical drug investigation.
J. Vencovský,
K. Pavelka,
J. Závada,
2019,
Expert opinion on biological therapy.
J. Klimeš,
T. Doležal,
A. Petříková,
2014,
Value in health regional issues.
J. Klimeš,
T. Doležal,
J. Vlček,
2014,
Value in health regional issues.
T. Doležal,
T. Mlčoch,
B. Decker,
2022,
International Journal of Technology Assessment in Health Care.
T. Doležal,
P. Ješina,
M. Lhotáková,
2018,
European Journal of Clinical Nutrition.
T. Watt,
T. Doležal,
J. Bartáková,
2021,
Expert review of pharmacoeconomics & outcomes research.
M. Procházková,
M. Votava,
J. Slíva,
2008,
Neuro - endocrinology letters.
T. Doležal,
M. Kršiak,
M. Soukupová,
2009,
Naunyn-Schmiedeberg's Archives of Pharmacology.
M. Procházková,
J. Slíva,
T. Doležal,
2006,
Basic & clinical pharmacology & toxicology.
J. Klimeš,
M. Campioni,
T. Doležal,
2014,
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
J. Klimeš,
T. Doležal,
K. Kruntorádová,
2014,
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
M. Tichý,
T. Doležal,
S. Gkalpakiotis,
2022,
The Journal of dermatological treatment.
M. Lukáš,
T. Doležal,
M. Bortlík,
2022,
Expert review of gastroenterology & hepatology.
T. Doležal,
M. Kršiak,
M. Soukupová,
2009,
Neuro endocrinology letters.
K. Kolasa,
V. Zah,
Z. Kaló,
2012,
Expert review of pharmacoeconomics & outcomes research.
Z. Kaló,
Z. Vokó,
T. Doležal,
2012,
European journal of cancer care.
A. Poprach,
B. Melichar,
T. Buchler,
2018,
Annals of oncology : official journal of the European Society for Medical Oncology.
M. Arenbergerova,
P. Arenberger,
T. Doležal,
2018,
The Journal of dermatological treatment.
T. Doležal,
Adam Doležal,
2014
.
Tomas Dolezal,
T. Doležal,
Tomas Mlcoch,
2019,
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
J. Klimeš,
T. Doležal,
2010
.
E. Havrdová,
G. Kobelt,
T. Kalincik,
2012,
Multiple sclerosis.
M. Mamas,
J. Matějka,
T. Doležal,
2023,
Expert review of cardiovascular therapy.
T. Doležal,
H. Doležalová,
V. Petrů,
2022,
Immunotherapy.
G. Petrova,
L. Marinov,
T. Doležal,
2011
.
T. Doležal,
2014
.
J. Klimeš,
T. Doležal,
A. Petříková,
2013,
Rheumatology International.
T. Doležal,
Adam Doležal,
2021,
Vnitrni lekarstvi.
P. Kratochvíl,
T. Doležal,
2014
.
J. Yfantopoulos,
M. Niewada,
Antonio Ramírez de Arellano,
2016,
Journal of medical economics.
J. Sevcík,
J. Štork,
M. Tichý,
2021,
Dermatology and Therapy.
D. Cerny,
T. Doležal,
2021,
Casopis lekaru ceskych.
M. Janovský,
J. Slíva,
T. Doležal,
2010,
Arzneimittelforschung.
Yacov Y. Haimes,
Duan Li,
Tomas Dolezal,
1993
.
E. Havrdová,
G. Kobelt,
T. Doležal,
2017,
Multiple sclerosis.
T. Doležal,
T. Mlčoch,
E. Ornstová,
2018,
Value in health regional issues.